Genentech’s Fenebrutinib Shows Promise for Relapsing Multiple Sclerosis in Two-Year StudyBusiness PenMay 30, 2025 May 30, 2025 Genentech, part of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), is making headway in the race to develop new treatments for multiple sclerosis (MS)....
